Detection of histological type and genetic mutation in lung cancer using ion mobility spectrometry
Not Applicable
- Conditions
- To investigate if IMS can diagnosis histological type and genetic mutation using volatile organic compounds (VOCs) in patients with lung cancer.
- Registration Number
- JPRN-UMIN000008328
- Lead Sponsor
- St. Marianna University School of Medicine Division of Respiratory and Infectious Diseases, Department of Internal Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1) To refuse to give informed consent 2) Lung cancer of unknown histological type 3) Patients with no diagnosis of lung cancer 4) Patients who are pregnant, possibly pregnant, or lactating. 5) Patients with renal failure. (serum creatinine > 2.0 mg/dL, BUN > 30mg/dl) 6) AST or ALT > 100IU 7) Patients with severe diabetes, hyperlipidemia or hyperuricemia 8) Patients who are judged inappropriate by the doctor in charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To investigate if IMS can diagnosis histological type and genetic mutation using volatile organic compounds (VOCs) in patients with lung cancer.
- Secondary Outcome Measures
Name Time Method